As of February 2025, China already had 60-70 late-stage (Phase 2 or later) pipeline assets, directly competing with semaglutide, tirzepatide and other candidates in diabetes and weight loss
"I'm hoping this year when they set us around the table that I can sit right in front of it and I can smile when I look at my reflection, feeling so good about myself because each day is a struggle," Casselman says
Individuals with underlying gastrointestinal conditions may experience more pronounced symptoms and should consult healthcare providers before initiating supplementation
By 2026 that figure had risen to 11.4% meaning roughly one in nine dollars of employer drug spending now goes to this single medication class
They have a 2.5-star review on TrustPilot
And while some of these ingredients have modest evidence for metabolic benefits when taken orally, the evidence for skin absorption is essentially nonexistent